OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review
Rami Burstein, Andrew Blumenfeld, Stephen D. Silberstein, et al.
Headache The Journal of Head and Face Pain (2020) Vol. 60, Iss. 7, pp. 1259-1272
Open Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

Advancements in the management of overactive bladder in women using nano-botulinum toxin type A: A narrative review
Yongheng Zhou, Qinggang Liu, Huiling Cong, et al.
Current Urology (2025) Vol. 19, Iss. 2, pp. 77-83
Open Access

Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review
Antonio Russo, Luigi Francesco Iannone, Ilaria Orologio, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 192-192
Open Access

The Noiseless Battle: Understanding Headache Torment
Gayathri. Vana, Imaraka. Charishma, Vaddadi. Poojitha, et al.
(2025), pp. 2783-2798
Closed Access

Real-World Insights into the Effectiveness and Tolerability of OnabotulinumtoxinA in Chronic Migraine: A Long-Term Evaluation of up to 11 Years
Antonio Santoro, Andrea Fontana, Massimiliano Copetti, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 208-208
Open Access

OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patients
Lisa Gfrerer, Wenjie Xu, William G. Austen, et al.
Brain (2021) Vol. 145, Iss. 7, pp. 2436-2449
Open Access | Times Cited: 25

Pharmacogenetics in Primary Headache Disorders
Irina I. Belyaeva, Anna G. Subbotina, Иван Иванович Еременко, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 17

Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study
Gabriele Sebastianelli, Francesco Casillo, Antonio Di Renzo, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 76-76
Open Access | Times Cited: 10

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
Aubrey Manack Adams, Susan Hutchinson, Ella Engstrom, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 10

Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response
Gabriella Juhász, Kinga Gecse, Dániel Baksa
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108523-108523
Open Access | Times Cited: 10

Headache Disorders: Differentiating Primary and Secondary Etiologies
Jairo Hernandez, Eduardo Molina, Ashley Rodriguez, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 2
Open Access | Times Cited: 3

Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
Amira Salim, Elise Hennessy, Claire Sonneborn, et al.
CNS Drugs (2024) Vol. 38, Iss. 6, pp. 481-491
Open Access | Times Cited: 3

Improving Spasticity by Using Botulin Toxin: An Overview Focusing on Combined Approaches
Loredana Raciti, Gianfranco Raciti, Antonio Ammendolia, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 631-631
Open Access | Times Cited: 3

Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management
Patricia Pozo‐Rosich, Alicia Alpuente, Stephen D. Silberstein, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 555-568
Closed Access | Times Cited: 3

The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review
Martina Ferrillo, Eleonora Sommadossi, Loredana Raciti, et al.
Toxins (2025) Vol. 17, Iss. 2, pp. 91-91
Open Access

Differences in pharmacological migraine treatment across different levels of clinical headache care – a cross-sectional study
Mira Pauline Fitzek, Lucas Hendrik Overeem, Ulrich Martin, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access

Evidence-based guidelines for the pharmacological treatment of migraine
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia (2025) Vol. 45, Iss. 4
Closed Access

FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine
Lars Jacob Stovner, Knut Hagen, Erling Tronvik, et al.
Cephalalgia (2022) Vol. 42, Iss. 7, pp. 590-597
Open Access | Times Cited: 16

OnabotulinumtoxinA effects on trigeminal nociceptors
Ashley A Moore, Mariana Nelson, Christopher Wickware, et al.
Cephalalgia (2023) Vol. 43, Iss. 2
Open Access | Times Cited: 9

Microbiological and Physiological Effects of Pain
Max Y. Jin, Erin S. Everett, Alaa Abd‐Elsayed
Current Pain and Headache Reports (2023) Vol. 27, Iss. 6, pp. 165-173
Open Access | Times Cited: 8

Habituation to Pain in Patients with Chronic Pain: Clinical Implications and Future Directions
Maite M. van der Miesen, Catherine J. Vossen, Elbert A.J. Joosten
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4305-4305
Open Access | Times Cited: 8

Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10975-10975
Open Access | Times Cited: 14

Mechanism and clinical use of botulinum neurotoxin in head and facial region
Swarnalakshmi Raman, Yumiko Yamamoto, Yoshitaka Suzuki, et al.
Journal of Prosthodontic Research (2023) Vol. 67, Iss. 4, pp. 493-505
Open Access | Times Cited: 7

Scroll to top